In this study, proteomic profiling revealed significant activation of the BCR and NF-κB/c-Rel signaling pathways in MG patients, a finding validated by upregulated NF-κB/c-Rel expression via western blot analysis. The gene discussed is NFKB1; the disease is myasthenia gravis.